Eli Lilly (LLY) Finalizes $2.8B AtaiBeckley Acquisition for Depression Treatment Pipeline
Eli Lilly (LLY) completed its $2.8B AtaiBeckley acquisition on Sept 11, 2026. Shareholders received $6.75/share plus CVRs worth up to $2.50 more.
The post Eli Lilly (LLY) Finalizes $2.8B AtaiBeckley Acquisition for Depression Treatment Pipeline appeared first on Blockonomi.
Source: Source: Blockonomi